Zhen Luo

Dr. Luo joined Refractal in 2020. She has years of industry experience in assay development and commercialization in biotechnology. Prior to joining Refractal, she was a staff scientist, and manager of R&D. Dr. Luo has authored 20+ papers in peer-reviewed journals and conferences. She also holds multiple commercialized patents. Dr. Luo received her Ph.D. in Bioengineering from UC Davis, where she was awarded NIH T32 Fellowship for her clinical research in cancer diagnosis.